Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SEB | FCN |
|---|---|---|
| Price | $3,978.74 | $138.02 |
| Change today | ▼ 1.13% | ▲ 1.19% |
| Market cap | $3.81B | $3.81B |
| Return, 3 months | -10.6% | -12.9% |
| Return, year to date | -10.4% | -19.2% |
| Return, 1 year | +13.4% | -14.3% |
| P/E (TTM) | 6.0 | 16.7 |
| P/B | 0.7 | 2.9 |
| P/E percentile vs own 5y | – | 1st |
| Dividend yield | 0.23% | – |
| Revenue growth (YoY, latest qtr) | +7.1% | – |
| Net profit growth (YoY) | +456.7% | – |
| Gross margin | 8.1% | – |
| Operating margin | 3.4% | – |
| Net margin | 6.2% | – |
| Return on equity | 12.3% | – |
| Analyst target vs. price | – | +19.9% |
| Analyst buy share | – | 33% |
| RSI (14) | 40 | 44 |
| 30-day volatility | 30.8% | 32.3% |
| Max drawdown, 1 year | -34.3% | -30.3% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
